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Background: Biocatalyst improvement through molecular and recombinant means should be complemented with
efficient process design to facilitate process feasibility and improve process economics. This study focused on
understanding the bioprocess limitations to identify factors that impact the expression of the terminal hydroxylase
CYP153A6 and also influence the biocatalytic transformation of n–octane to 1-octanol using resting whole cells of
recombinant E. coli expressing the CYP153A6 operon which includes the ferredoxin (Fdx) and the ferredoxin
reductase (FdR).
Results: Specific hydroxylation activity decreased with increasing protein expression showing that the
concentration of active biocatalyst is not the sole determinant of optimum process efficiency. Process physiological
conditions including the medium composition, temperature, glucose metabolism and product toxicity were
investigated. A fed-batch system with intermittent glucose feeding was necessary to ease overflow metabolism
and improve process efficiency while the introduction of a product sink (BEHP) was required to alleviate octanol
toxicity. Resting cells cultivated on complex LB and glucose-based defined medium with similar CYP level
(0.20 μmol gDCW-1) showed different biocatalyst activity and efficiency in the hydroxylation of octane over a period
of 120 h. This was influenced by differing glucose uptake rate which is directly coupled to cofactor regeneration
and cell energy in whole cell biocatalysis. The maximum activity and biocatalyst efficiency achieved presents a
significant improvement in the use of CYP153A6 for alkane activation. This biocatalyst system shows potential to
improve productivity if substrate transfer limitation across the cell membrane and enzyme stability can be
addressed especially at higher temperature.
Conclusion: This study emphasises that the overall process efficiency is primarily dependent on the interaction
between the whole cell biocatalyst and bioprocess conditions.
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The linear paraffins from expanding activities in the
petrochemical industry provide an inexpensive hydrocar-
bon feedstock. The use of micro-organisms as biocata-
lysts for the production of value added chemicals using
this non-conventional substrate has gained interest due
to the difficulty in achieving efficient process economics
with chemical catalysts owing to the inert nature of the
reactant. Cytochrome P450 monooxygenases (CYPs) have
the ability to hydroxylate a wide range of substrates by the
regio-and/or stereo-specific insertion of an oxygen atom
into a carbon-hydrogen bond at physiological pressure
and temperature (Figure 1). This leads to reduced by-
product and waste generation, and thereby potentially
reduced environmental burden. The use of this enzyme as
biocatalyst on a large scale is hampered by factors such as
low enzyme activity, substrate and product toxicity, bioca-
talyst stability and the requirement for reduced co-factors
[1-3]. Various studies have been conducted to address the
aforementioned shortcomings using whole cells, the pre-
ferred option over free enzymes for alkane activation.
These have used a selection of enzymes from the CYP
family. The CYP153s have the advantage of terminal al-
kane hydroxylation with selectivity of over 95%, a notable
advantage over biocatalysts performing similar functions
including the well-studied alkane mono-oxygenase (alkB)
from Pseudomonas. They catalyse the hydroxylation of
lower to medium chain linear alkanes, C4-C11, with octane
as preferred substrate [4-8].
In biocatalysis, productivity is a function of biocatalyst
activity. This can be maximised by protein engineering
using molecular techniques or by adopting a bioprocess-
based approach. To date, most studies on CYPs as bioca-
talysts have focused on the use of molecular methods to
manipulate and improve enzyme properties, with theNAD(P)H + H+
R –H + O2+
FdR
Fd
Cellular met
Figure 1 The schematic representation of the various reactions of the
system within a whole cell. The ferrodoxin reductase (FdR) transfers elect
ferrodoxin (FdX), to the hydroxylase protein CYP153A6 for the oxidation ofprocess and reaction engineering given less attention. Mo-
lecular methods for enzyme engineering such as rational
design, directed evolution and site directed mutagenesis
have been reported to yield up to 8-fold improvement for
CYP whole-cell processes while increments of over 25-
fold have been achieved by considering factors such as mi-
crobial host selection, reaction and process optimisation
[3,9-15]. For the hydroxylation of alkanes using whole cell
biocatalysts expressing CYP153s, significant studies have
centred on the choice of host organism, vector systems
and other molecular tools to improve protein expression
and whole cell activity [4,5,8,16-18]. Although this has led
to meaningful progress in biocatalyst design, productivity
in most in vivo alkane biotransformation studies fall out-
side the operating window described as essential for fine
chemical synthesis, a minimum of 0.1 g-1 l-1 h-1 [12]. The
system is often characterised by poor activity and low
stabilities, resulting in short reaction time and unaccept-
able productivity. In a recent study to improve the recom-
binant expression of CYP153A6 using a pET vector,
Gudiminchi et al. [19] reported notable improvements in
biocatalyst activity and productivity. In this study, the
major influence resulted from biocatalyst loading, increase
in oxygen content and choice of carbon source to supply
energy and reducing equivalents for biotransformation.
Although the biocatalyst efficiency achieved was over 12
fold better than literature values, the factors constraining
further process improvement were not well understood.
From the studies, it was apparent that the overall process
efficiency is dictated by the physiological state of the cell,
determined by the interaction between whole cell bioca-
talyst, bioprocess conditions and their history. The
physiology of whole cell biocatalyst during long term bio-
transformation is largely unknown and may also be re-
sponsible for dynamic biocatalyst activities and stabilities,NAD(P)+
R –OH + H2O
CYP
x
abolism
alkane hydroxylase protein (CYP153A6) and its electron transfer
rons from NAD(P)H through a small electron transfer protein,
the alkane substrate to its alcohol equivalent.
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logical factors include overexpression of the cloned gene
(s), supply of nutrients and growth factors through the
growth medium and mass transfer, product toxicity, and
cofactor regeneration [20,21]. These environmental process
conditions determine the extent to which the maximum
active enzyme concentration achieved in cell cultivation is
exploited in the alkane bioconversion phase. Therefore, in
conjunction with strain development and metabolic engin-
eering, it is important that parameters that constrain
physiological state and subsequent process performance be
considered to improve the specific biocatalyst activity and
productivity. These include cell environmental factors that
impact the expression level of the cloned gene, biocatalyst
activity and stability.
In this study, the expression of the CYP153A6 gene pro-
duct in E. coli, its activity, stability and octane biotrans-
formation to 1-octanol were investigated as a function of
induction conditions, FeCl3 concentration, temperature,
glucose availability to facilitate co-factor regeneration and
product toxicity. The influence of overflow metabolism and
product toxicity were assessed to inform further process
development.
Results
Expression of CYP153A6 in a batch process
Temperature
For the growth temperature studies, a flask culture was
allowed to proceed at the same temperature for both the
growth and expression phases while a second flask was
incubated at the test temperature for growth and a
reduced temperature of 20°C after induction for enzyme
expression. The results presented in Table 1 show that
there was no substantial difference in CYP153A6 concen-
tration (0.16 to 0.20 μmol per g dry cell weight, DCW)
when pre-induction temperatures of 20, 25, 30 and 37°C
were used, giving a final octanol concentration of 0.80 –
1.00 g gDCW
-1. When incubation following induction wasTable 1 Effect of temperature conditions on growth rate,
CYP153A6 expression and subsequent bioconversion of
octane to 1-octanol in a 72 h reaction
Temperature Maximum growth rate [CYP] 1-Octanol
(°C) μmax (h
-1) (μmol gDCW
-1) (g gDCW
-1)
A B A B
20 0.20 0.17 0.16 1.00 1.00
25 0.37 0.20 0.06 1.00 0.50
30 0.50 0.17 0.00 0.80 0.00
37 0.82 0.16 0.00 0.85 0.00
Under condition A, the temperature was maintained as specified prior to
induction, whereafter incubation was at 20°C. Under condition B, the specified
temperature was maintained throughout cultivation, expression and
bioconversion. DCW, dry cell weight.continued at the initial growth temperature, CYP450 ex-
pression was affected negatively at the higher tempera-
tures (25 – 37°C). The concentration of active enzyme in
the cells incubated at 25°C was reduced by 3-fold relative
to that at 20°C, leading to a 50% decrease in 1-octanol
formation. No active P450 enzyme was observed in the
cells incubated at 30 and 37°C. This was confirmed at the
bioconversion stage with no octanol detected in biotrans-
formations with cells following CYP expression at 30 and
37°C following induction.
Induction conditions in a batch process
The mid exponential phase of cell growth was determined
as the preferred point for addition of inducer for optimal
expression and activity of CYP153A6 by LB-grown cul-
tures (data not shown). Further, the minimum effective
inducer (IPTG) and heme precursor (δ-ALA) concentra-
tions per unit biomass were determined by simultaneously
varying IPTG and δ-ALA concentrations from 0.05 to
1 mM (10 to 220 μmol gDCW
-1). A defined medium con-
taining glucose, adapted from Pflug et al. [14] was selected
for this study to improve the volumetric CYP153A6 con-
centration through increasing the biomass concentration.
The P450 content, 1-octanol over a biotransformation
period of 70 h and biocatalyst efficiency are presented in
Figure 2. Relative to the control run (no induction), cell
induction at mid-exponential phase did not inhibit bio-
mass formation (an average of 4.5 ± 0.2 g l-1) across the
range of inducer concentration studied (0.05 to 1 mM).
The maximum CYP153A6 expression of 0.80 μM, trans-
lating into 0.20 μmol gDCW
-1 was observed in the inducer
concentration range of 0.25 to 1.00 mM. In biotransfor-
mations, the maximum biocatalyst efficiency (octanol
formed per unit of active CYP153A6) of 120 μmol nmol-1
was observed when the IPTG concentration was
0.05 mM. This dropped with increasing CYP concentra-
tion, remaining constant above an IPTG concentration of
0.25 mM as the CYP concentration remained constant.
The reduction in specific product formation with
increased CYP153A6 expression at higher inducer con-
centration suggests a limiting factor in the octane biocon-
version process.
The impact of iron on the expression of the hemopro-
tein, CYP153A6, and whole cell biocatalyst activity was
investigated by varying the FeCl3.6H2O concentration
from 0 to 1000 μM. FeCl3.6H2O was added with IPTG
and δ-ALA at the time of induction in both LB and
glucose-based defined medium. The data presented in
Figure 2 show that FeCl3 addition caused more than a
2-fold increase in CYP concentration in the defined
medium, even at the minimum concentration of 50 μM.
Further increase in FeCl3 concentration up to 1000 μM
did not improve CYP concentration which remained at
around 0.20 μmol gDCW
-1. This trend was not reflected in
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Figure 2 Effect of IPTG and δ-ALA concentration on CYP153A6 expression, whole-cell octane biotransformation in 70 h and the
resultant biocatalyst efficiency with cells grown on defined medium. Dry biomass concentration was an average of 4.5 ± 0.2 g l-1 across
inducer concentrations.
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http://www.microbialcellfactories.com/content/12/1/8the hydroxylation of octane by the resting cells as whole
cell activity was in the range of 3 to 3.5 μmoloctanol
(gDCW min)
-1, with or without FeCl3 addition (Figure 3).
The results from LB complex medium did not show a
major difference in CYP expression (0.17 to 0.19 μmol
gDCW
-1) with FeCl3 concentration in the range of 5 to
1000 μM relative to the control without FeCl3 added
(0.15 μmol gDCW
-1). The rate of octanol formation varied
between 4 and 5 μmol (gDCW min)
-1 with FeCl3 in the0.00
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0 200 400 600
FeCl3(
Figure 3 Impact of FeCl3 concentration on CYP153A6 expression in L
was re-suspended in 0.2 M Sodium Phosphate buffer containing glucose a
determined using biomass from both LB {□} and chemically defined mediurange of 0 to 100 μM. A further increase in iron concen-
tration resulted in reduced biocatalyst activity (Figure 3).
Whole cell hydroxylation of n-octane
Further experiments to understand limiting factors in
octane bio-oxidation were conducted using resting cells
grown in LB and glucose-based chemically defined
medium. The conditions that favour the maximum ex-
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http://www.microbialcellfactories.com/content/12/1/8cultivation and protein expression prior to the use of
biomass in bioconversion.
Temperature - rate of reaction and biocatalyst stability
To investigate the effect of temperature on the bioconver-
sion of octane using resting E. coli cells, the bioprocess
temperature was varied from 20 to 37°C. The maximum
rate of product formation and the thermal stability of the
whole cell biocatalyst were determined. The maximum bio-
catalyst activity of 16 μmoloctanol (gDCW min)
-1 was achieved
at 37°C, with the octanol concentration reaching 0.48 g
gDCW
-1 in 6 h (Table 2). This represents a 4 fold increase
over the value achieved at 20°C and previously reported
by Gudiminchi et al. (2012). However, octanol accumula-
tion was limited by biocatalyst instability at the higher
temperature. Attempts to alleviate protein instability
through the addition of glycerol did not result in any posi-
tive influence.
Glucose fed-batch process
The effective utilisation of glucose as energy source for
product formation is necessary for process efficiency of
bioconversion [22]. The preferred use of glucose as en-
ergy source by this whole cell biocatalyst was high-
lighted in a previous study [19]. It was, however, also
demonstrated that increasing the glucose concentrationTable 2 Comparison of key bioprocess parameters obtained i
production using E. coli and cytochrome P450, especially the
Fujii et al.,
2006
Baik,
2010
Bordeaux
al., 2011
E. coli biocatalyst CYP153Aci
CYP, Fdx&
Fdr
CYP153A1
Growth medium L-Broth
Marine
Broth
n/a
Bioreactor Vial Shaker n.a.
Temperature (°C) 28 37 23 ± 1
Biomass concentration
n.a. n.a n.a.
(g LBRM
-1)
Max octanol formed
2.3 0.45 n.a.
(g LBRM
-1)
Time max octanol (h) 24 6 2
Max volumetric rate
0.1 0.07 n.a.
(g LBRM
-1 h-1)
Biocat efficiency at max octanoll
n.a. n.a. 0.06
(goctanol gDCW
-1)
Max specific octanol formation rate
per biomass n.a. n.a. 3.9
(μmol min-1 gDCW
-1)
Periodmax rate (h) 0 – 24 2 – 6 0 – 2
(a)Figure 5A (b)Figure 6.beyond a critical value did not result in improved octa-
nol accumulation, suggesting over-metabolism towards
by-product formation. It was observed in several experi-
ments that acetic acid (an indicator of overflow metab-
olism) reached a concentration of up to 2.5 g l-1 when
glucose was added above a concentration of 10 g l-1
(1.0 g gDCW
-1). It lowered the pH of the reaction mix-
tures from pH 7.2 to 5.6. This concentration of acetic
acid was confirmed as partially inhibitory (by 35%) to-
wards octanol formation in an experiment in which dif-
ferent concentrations of acetic acid (up to 10 g l-1) were
added to the reaction mixtures (Figure 4A). Further in-
vestigation was conducted to ease overflow metabolism
and also alleviate “glucose uncoupling” from the desired
product formation by adopting a fed-batch approach. In
this experiment, a glucose concentration in the range of 2
to 5 g l-1 (0.5 to 1.0 g gDCW
-1) was maintained through
intermittent glucose supplementation in fed- batch to
prevent limitation (Figure 5B). In Figure 5A, it is seen
that octanol accumulation of 0.9 g gDCW
-1 was achieved
in 48 h at a maximum rate of 3.17 μmol (gDCW min)
-1.
Acetic acid formation was also reduced by 40% to 1.5 ±
0.2 g l-1. Although this result implies that this by-
product is not the only factor limiting increased octanol
accumulation, the process efficiency was improved by
reducing over-oxidation of glucose to by-products.n this study with previous reports on 1-octanol
CYP153 operon
et Koch, et al.,
2009
Gudiminchi,
2012
This
studya
This
study This study
b
3 CYP153A6 CYP153A6 CYP153A6 CYP153A6 CYP153A6
Semi-defined LB LB LB
Defined
medium
Vial Vial Vial Vial Vial
25 20 20 37 20
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0.01 8.8 6.5 2.2 6.0
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Figure 4 Whole cell biocatalyst inhibition studies conducted by pre-adding (A) acetic acid (B) 1-octanol, to the reaction mixture at the
start of octane hydroxylation. Biomass concentration was 4 g LBRM
-1 with an initial glucose concentration of 5 g l-1. The end-point
concentration was determined after 75 h of reaction in 40 ml amber vials.
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defined medium
To understand the impact of product toxicity on octanol
accumulation, 1-octanol was pre-added to the reaction
mixture in the concentration range of 0 to 50 mM (0 to 2 g
gDCW
-1) and the reaction was allowed to continue for 72 h
using cells grown in LB medium. The results show that
product toxicity was experienced with increasing octanol
concentration leaving about 17% product formation0.00
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Figure 5 (A) Whole cell biotransformation of octane with intermittent
a 40 ml vial using 1 ml bioreaction mixture and 300 μl octane. Active
concentration and acetic acid formation were monitored.capacity at octanol concentration of 0.8 g gDCW
-1 and no
conversion at 1.25 g gDCW
-1 (Figure 4B). Although exter-
nally added product may not mimic the effects of intracel-
lularly produced octanol completely, the results confirm
the inhibitory nature of the product. To alleviate this effect,
a second organic phase was investigated for in situ product
recovery. Two solvents, 1-hexadecene and bis (2-ethyl-
hexyl) phthalate (BEHP) were used for this study. BEHP
was preferred as a carrier solvent owing to its ability toCY
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glucose feeding using a biomass concentration of 3.6 g LBRM
-1 in
CYP153A6 was also observed over duration of reaction. (B) Glucose
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http://www.microbialcellfactories.com/content/12/1/8maintain the maximum conversion rate and to the appa-
rent alkane mass transfer limitation experienced with
hexadecene. The maximum 1-octanol produced with
hexadecane was limited to only 0.30 g gDCW
-1 in 60 h.
With BEHP as a carrier solvent, the maximum rate of
product formation was maintained at 4 μmoloctanol (min
gDCW)
-1 reaching a concentration of 1.20 g gDCW
-1 in 48 h.
This represents a 50% increase in overall conversion over
that achieved without a carrier solvent under the same
condition (Figure 6A, Table 2). The product toxicity was
less intense when BEHP was added as carrier solvent as
depicted by the cell metabolism illustrated by glucose util-
isation (Figure 6B). The rates of glucose consumption for
the resting whole cell biocatalyst in glucose solution with-
out substrate, and the resting whole cells in glucose solu-
tion with octane or octane and BEHP added were similar
up to 24 h (0.48 mmol gDCW
-1 h-1). However, a difference
in glucose utilisation was noticed in the second 24 h
period, especially between 34 to 48 h. During this period
the glucose consumption rate was the highest for the rest-
ing cells with octane and BEHP added. These cells con-
sumed almost twice as much glucose as the control cells
without substrate, demonstrating that the whole cell bioca-
talyst was able to increase its metabolism to respond to
increased carbon demand for the increased cofactor regen-
eration required by octane hydroxylation. The glucose con-
sumption rate of the cells with only octane added was the
lowest, showing that the resting whole cell biocatalyst was
susceptible to product inhibition if a product sink was not
available to reduce its concentration in the aqueous phase.0.00
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Figure 6 (A) Whole cell hydroxylation of n–octane using biomass from
phthalate. The bio-reaction mixture consisted of 1 ml re-suspended cells (
organic phase consisting of 100 μl BEHP. (B) Glucose concentration was m
as a control system (without organic phase). The vials were opened interm
oxygen limitation. The reaction was mixed on an orbital shaker at 200 rpmHowever, octanol accumulation levelled off after 48 h ap-
parently due to the decrease in pH from 7.2 to 5.4 ± 0.2.
A similar experiment was carried out with cells cultured
on defined medium. This experiment again demonstrated
the effect of product inhibition clearly and its reduction by
product removal into the BEHP phase. When no BEHP
was added, product formation was almost linear for more
than 25 h but ceased after 48 h. In comparison, it
remained almost linear in excess of 50 h when BEHP was
added and continued to be formed until 120 h. Thus with-
out a carrier solvent, a maximum octanol concentration of
0.65 g gDCW
-1 was achieved after 60 h, compared with
1.10 g gDCW
-1 at 60 h and a maximum octanol concentra-
tion of 1.45 g gDCW
-1 after 120 h when BEHP was added
as co-solvent (Figure 7, Table 2).
Notable features of the reactions carried out with cells
grown in chemically defined medium were the slower re-
action rate and the longer time for which the biocatalyst
remained active when compared with the LB grown
cells. The result presented in Figure 8 shows that max-
imum activity was maintained at its highest value for the
first 24 h with LB cells, whereafter it decreased linearly,
exhibiting no activity at 75 h. For cells cultured on
defined medium, the whole cell biocatalyst activity grad-
ually increased, peaking at approximately 2.5 μmoloctanol
(min gDCW)
-1 at 24 h where it was maintained until 48 h
before it decreased gradually to 1.5 μmoloctanol (min
gDCW)
-1 at 120 h, and rapidly decreased to a nil point at
140 h. Since the CYP concentration was initially the same
in both LB and defined medium (0.20 μmol gDCW
-1), this0.00
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ittently for glucose addition and also to allow air inlet to prevent
and 20°C.
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Figure 7 Whole cell hydroxylation of n-octane using resting
cells grown on glucose based defined medium. The biomass was
harvested and re-suspended (4 gDCW l
-1) in 0.2 M Sodium Phosphate
buffer, pH 7.2 consisting of glucose (starting concentration of
5 g l-1). A 1 ml aliquot of this mixture was introduced into the
60 ml amber vials and 30% v/v organic phase consisting of 200 μl
octane and 100 μl BEHP was added. In another set, only octane
(300 μl) was added. The vials were opened intermittently for glucose
addition and also to allow inlet of air to prevent oxygen limitation.
The reaction was mixed on an orbital shaker at 200 rpm and 20°C.
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http://www.microbialcellfactories.com/content/12/1/8result suggests that the different medium composition con-
ferred a different physiological state on the cells, thereby
affecting their metabolic response and hydroxylation cap-
ability in octane biotransformation.
Cell permeabilisation and biocatalyst activity
The potential limiting effect of alkane transfer into the
cells was studied by permeabilising the cell membrane
using acetone or toluene in the concentration range of 5
to 20% v/v. Reactions were conducted at 23 and 37°C.
Initial results with toluene or high concentrations of
acetone (>5% v/v) showed cell aggregation and whole cell0.0
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Figure 8 Comparison of rate of octanol formation between
cells cultivated on LB and defined medium, and subsequently
used for octane biotransformation in 60 ml amber vials.inactivation. No octanol formation was observed (data not
shown). Further studies were conducted with 5% acetone.
The results presented in Table 3 show the influence of
acetone pre-treatment on the biotransformation rate. At
23°C, cells grown in either LB or chemically defined
medium showed a two fold increase in octanol formation
rate with acetone pre-treatment. This trend was also
observed with defined medium grown cells at 37°C. On
LB at 37°C, a decrease in whole cell biocatalytic activity
was apparent. This suggests that acetone increases the
permeability of the cell membrane towards the alkane
substrate, thereby increasing mass transfer rates. The
difference observed with LB grown cells at higher
temperature suggests some physiological limitation which
is explained later.
Discussion
Expression of CYP153A6 in recombinant E. coli
Studies were carried out to inform the bioprocess factors
that govern the biocatalytic activity of CYP153A6 in re-
combinant E. coli and its effect on the accumulation of
1-octanol in the biotransformation of n-octane and ma-
nipulation of these factors to improve biocatalyst activity
and efficiency. The role of cultivation parameters such as
temperature, induction conditions and supply of nutrients
were investigated with respect to its effect on CYP153A6
expression driven by the T7 promoter in a recombinant
E. coli BL21(DE3) strain carrying the pET28b-PFR1500
plasmid. Performance of the resultant whole cell biocata-
lyst under various biotransformation conditions was
determined.
Reduced temperature usually helps to control meta-
bolic fluctuations and protein synthesis rate thereby
avoiding the formation of insoluble protein aggregates
typical of cells at higher growth rate [23]. In the case of
CYP153A6 expression, post-induction temperatures of
25°C and above yielded very little or no properly folded
active P450. To further improve protein concentration
and possibly improve gene expression, a glucose-based
defined medium was investigated due to an expected in-
crease in biomass concentration [24]. This necessitated
varying inducer concentration (IPTG), as previous inves-
tigations have suggested that inducer concentration
should be determined on a basis of biomass concentra-
tion [25]. The concentration of δ-ALA which is required
for heme synthesis was varied simultaneously across the
same range. Again, increased concentration of active
biocatalyst does not necessarily guarantee the higher hy-
droxylation rate [19]. Previous studies involving the use
of E. coli as whole cell biocatalyst in alkane hydroxyl-
ation have also shown that specific activity was inde-
pendent of expression levels of alkane mono-oxygenase
in different E. coli hosts [26]. These observations thus
support findings from a previous study that microbial
Table 3 Hydroxylation of n-octane using permeabilised cell in 60 ml amber vials
Medium Defined Defined Defined Defined LB LB LB LB
Pre-treatment None Acetone None Acetone None Acetone None Acetone
Temperature (°C) 23 23 37 37 23 23 37 37
Max specific octanol formation rate per biomass
4.17 8.47 6.59 11.11 5.26 9.10 16.09 14.97
(μmol min-1 gDCW
-1)
NB: Cell concentration, 3 – 4 gDCW l
-1; reaction time, 2 h at 37°C & 6 h at 23°C; initial CYP concentration, 0.20 μmol gDCW
-1.
The cells were pre-treated with acetone (5% v,v) prior to biotransformation.
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catalysed bioprocesses [20,21]. Hence, further investigations
were aimed at understanding the bioprocess limitations that
contribute to cell physiology in octane bio-oxidation.
Hydroxylation of n-octane in a batch and fed-batch
reaction using cells cultured on complex LB and
glucose-based defined medium
The key bioprocess parameters and results presented in
Table 2 shows a relatively improved process for 1-octanol
production using resting whole E. coli cells expressing
cytochrome P450 in this present study. The highest bioca-
talyst activity(16 μmol gDCW
-1min-1) in this study at 37°C
presents a minimum of 4-fold increase over data from
previous studies using the CYP153 protein in alkane
hydrolysis. CYP153A6 is unfortunately not stable at this
temperature and the activity was maintained for only 6 h.
The addition of glycerol to the biotransformation mixture
did not alleviate biocatalyst instability, even though it is
often regarded to have a stabilising role in recombinant E.
coli - CYP450 biocatalysis systems [17]. Therefore, further
experiments were conducted at 20°C to understand other
factors influencing octane hydroxylation activity.
A fed-batch mode of glucose addition was adopted to
ease overflow metabolism as by-products such as acetic
acid reduce reaction pH and also inhibit metabolism
[27,28]. This fed-batch system led to reduced acetic acid
formation (which was prevalent in the batch system at glu-
cose concentration above 1 g gDCW
-1), thus improving the
coupling of glucose usage to product formation which is es-
sential for enhanced process efficiency [22]. In addition, this
reduces the potential formation of octylacetate (condensa-
tion of octanol with acetate) which has been observed at
very high glucose concentration in a batch system (Smit,
personal communication). Further process intensification
identified product toxicity as a limiting factor. Using cells
grown on LB medium, it was observed that 1-octanol con-
centrations as low as 0.25 g gDCW
-1 inhibited biocatalyst
activity when added at the start of the reaction. However,
the cells were able to tolerate increasing 1-octanol pro-
duced during the reaction up to 0.8 g gDCW
-1 (Figure 6A.)
It suggests the ability of the whole cells to adapt the cell
membrane to the toxic nature of the increasing concentra-
tion of product secreted into the medium. Solvent toxicityis usually described using the logarithm of the partition
coefficient P of a particular solvent between a standardised
1:1 mixture of octanol and water, log POW [29]. Low log
POW solvents (log POW < 4) are regarded as highly toxic
due to their relative water solubility and ease partitioning
within the cell membrane. This causes membrane fluidity
and permeability leading to leakages, disruption in energy
metabolism and cell death. Octanol has a logPOW of 2.9,
hence the need to alleviate its impact on the cell cytoplas-
mic membrane where it accumulates preferentially. Tox-
icity of octanol was relieved by the addition of BEHP
which acted as a co-solvent and product sink. This pro-
longed the time that the cells remained catalytically active
and increased the final octanol levels obtained with LB
grown cells from 0.80 to 1.25 g gDCW
-1 after 60 h. It had
an even more pronounced effect on the conversions
obtained with cells grown in chemically defined medium.
In this case the cells without BEHP remained active for
only 48 h, while the cells with BEHP added maintained ac-
tivity for 120 h, so that a final octanol production of 1.45 g
gDCW
-1 was obtained, compared with only 0.65 g gDCW
-1
in the absence of BEHP. The addition of the BEHP did not
affect the reaction rate but extended the time over which
the cells remained active. Notable was the lower reaction
rates obtained with cell grown in chemically defined
medium (2.40 μmoloctanol gDCW
-1min-1), compared with LB
grown cells (4.2 μmoloctanol gDCW
-1min-1), even though the
CYP153A6 expression was similar (0.20 μmol gDCW
-1).
This may be explained by the difference in glucose uptake
rate, 0.48 and 0.30 mmol (gDCW h)
-1 for LB and defined
medium cells respectively. It is supported by the similar
octanol yield on glucose of 0.49 ± 0.06 mmol-1 mmol-1 in
both systems. Glucose metabolism is directly coupled to
cofactor regeneration and cell energy which are required
for effective substrate conversion [30]. Other effects might
also include the presence of essential metabolites in com-
plex medium which may have aided the cofactor pool or
improved flux of NAD(P)H to the enzyme system thus in-
fluencing the product formation rate [31]. The physiology
conferred on the cells grown in defined medium may also
explain the different metabolic pattern shown during oc-
tane biotransformation. Although rate of octane hydroxyl-
ation was slower to reach its peak, the decrease was also
slower, with the cells actively producing octanol up to
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grown cells. It is likely that this pattern shown in octane hy-
droxylation may be due to cell metabolism as depicted by
glucose uptake rate. The cessation of octanol accumulation
using the complex LB and defined medium cultured bio-
mass is apparently due to the decrease in the pH of the re-
action mixture from pH 7.2 to 5.4 ± 0.2.
Attempts to improve biocatalyst activity by pre-treating
with acetone to permeabilise the cells yielded up to 2-fold
increase except where LB grown cells were used at the
higher temperature of 37°C. The latter could be due to
toxicity arising from high metabolic rate afforded by the
medium and temperature, aggravating the cell stress
caused by the compromised cell membrane and structure.
It has been shown that cells with higher metabolism are
more prone to chemical inactivation [32]. This result sug-
gests an apparent limitation of octane mass transfer across
the cell membrane. A similar effect of uptake limitation
has been reported for biotransformation of octane [33] and
n-dodecane [34] using E. coli expressing alkane monooxy-
genase. Octane hydroxylation rate was improved by 4 fold
through cloning an additional protein, AlkL, in the outer
membrane of the E. coli cells to facilitate efficient uptake of
the substrate [33]. The authors reported a better result
using this system over cell permeabilisation via chemical
agents. This shows that further strain design may be neces-
sary for enhanced activity.
Conclusion
This study provides the first detailed basis for process
intensification involving the use of CYP153A6 for the
hydroxylation of linear alkanes which is regarded as the
physiological substrate of CYP153s. The maximum rate
of 1-octanol formation of 16 μmol gDCW
-1 min-1 in this
system compares favourably with studies using alkane
hydroxylase (AlkB) expressed in E. coli. With the latter,
the product is usually subjected to further product oxi-
dation and degradation, negatively affecting downstream
processing cost [34]. Hence the CYP153A6 system is
favoured. The present study shows that the success of
this CYP process is not solely dependent on the concen-
tration of the active monooxygenase, but also on other
process conditions with cell physiology playing an im-
portant role. Composition of growth medium and supply
of nutrients (affecting cofactor pool and regeneration),
optimum process conditions (induction and temperature
studies) and process engineering (fed-batch supply of
glucose and in-situ product removal) were necessary to
enhance biocatalyst efficiency.
Blank et al. [35] estimated a maximum specific activity
of 370 μmol gDCW
-1min-1 for resting E. coli cells in oxyge-
nase biotransformation, based on an equimolar NADH/
product stoichiometry at a glucose uptake rate of 2.4 mmol
(gDCW h)
-1 allowing maximal NADH yields on glucose.From this prediction, it is apparent that the maximum hy-
droxylation activity achieved in this study was not limited
by the metabolic capacity of the whole cell biocatalyst.
This illustrates the ongoing scope for process improve-
ment through biocatalyst and bioprocess design to favour
increased CYP153A6 activity and stability.
Materials and Methods
Chemicals, bacterial strains and plasmids
Chemicals and antibiotics were obtained from Sigma-
Aldrich. E. coli BL21(DE3) pET28b-PFR1500 contain-
ing the CYP153A6 operon from Mycobacterium sp.
HXN-1500 cloned into plasmid pET28b(+) was used as
biocatalyst [19].
Pre-cultures, medium preparation and expression of
CYP153A6
Luria Bertani (LB) broth (tryptone 10 g l-1, yeast extract
5 g l-1 and NaCl 10 g l-1) supplemented with 30 μg ml-1
kanamycin was inoculated with E. coli BL21(DE3) pET28b-
PFR1500 glycerol stock (previously maintained at -60°C).
The pre-inoculum (50 ml in a 500 ml shake flask) was incu-
bated at 30°C and 160 rpm for 12 h. This was used to in-
oculate LB medium or defined medium adapted from Pflug
et al. [14] containing 10 g l-1 glucose at 2% v/v (using a
working volume of 200 ml in a 2 L flask). This was supple-
mented with 30 μg ml-1 kanamycin and incubated at 37°C
with constant shaking at 160 rpm. At A578nm of 0.6 – 0.8,
the medium was supplemented with, unless stated other-
wise, 0.5 mM δ-aminolevulinic acid (δ-ALA), 50 μM
FeCl3.6H2O and 0.5 μM isopropyl-β-D-thiogalactopyrano-
side (IPTG). Cultures were further incubated at 20°C,
160 rpm for a total of 24–26 h after inoculation.
Studies on CYP153A6 expression and whole cell activity
The effect of inducer concentration (0 – 1.0 mM IPTG)
and concentration of heme precursors (FeCl3.6H2O and
δ-ALA, 0 – 1.0 mM) on the expression of CYP153A6 was
investigated. These compounds were added at A578nm of
0.6 – 0.8 and cultures were incubated at 20°C. In another
set of experiments, the cultivation temperature preceding
and following induction was varied from 20 to 37°C.
Whole cell biotransformation
Following protein expression, the E. coli BL21(DE3) cells
were harvested through centrifugation at 7000 g and 4°C
for 10 min. The cell pellet was resuspended in 200 mM
sodium phosphate buffer (pH 7.2) containing glucose
and 100 μg ml-1 FeSO4.7H2O. This biotransformation
reaction mixture (BRM) was used for octane biotrans-
formation under non-growing, but metabolically active
conditions. One millilitre aliquots of this mixture was
transferred into 40 or 60 ml sterile amber screw cap vials
and 300 μl of n-octane added to each vial before capping
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(unless otherwise stated). Vials were removed at speci-
fied time intervals for product extraction. The biotrans-
formation reactions were stopped by adding 100 μl of
5 M HCl to each vial. The octanol, residual glucose and
acetic acid concentrations were determined.
Influence of bioprocess conditions on biocatalyst
efficiency
Non-growing, but metabolically active cells were used in
studying the influence of various bioprocess parameters
such as temperature, overflow metabolism, product tox-
icity and biocatalyst stability on octane biotransform-
ation. The glucose concentration at the start of reaction
was varied from 0.5 to 2.5 gglucose gDCW
-1. The preferred
concentration was used in another set of experiments to
study the influence of reaction temperature (20 - 37°C)
on product accumulation and CYP stability. For the tox-
icity studies, a carrier solvent into which the product
was selectively drawn was added using hexadecene or
bis(2-ethylhexyl) phthalate (BEHP), due to properties
such as recovery efficiency, non-toxicity to E. coli cells
and no interference with reaction mixture [36]. To 1 ml
of re-suspended biomass, 100 μl of the carrier solvent
and 200 μl of octane was identified as the preferred ratio
and added to the reaction mixture.
Effect of cell permeabilisation on whole cell biocatalyst
activity
To determine the extent of mass transfer in the reaction
vials, studies were carried out by pre-treating (permeabilis-
ing) the whole cell biocatalyst with acetone and toluene in
the range of 5 to 20% (v/v). The permeabilising agents
were added to the re-suspended cells (in 200 mM sodium
phosphate buffer, pH 7.2) and vortexed in an Eppendorf
tube for 2 – 3 mins. A 1 ml aliquot of the pre-treated cells
was transferred into the 60 ml reaction vial containing
300 μl of octane and 40 mM glucose (final concentration).
This was mixed on an orbital shaker at 200 rpm while
temperature was maintained at either 23 or 37°C.
Analytical Methods
Quantification of cell growth and substrate utilisation
Biomass concentration was measured gravimetrically as
cell dry weight and by absorbance at A578nm. Glucose util-
isation was analysed by determining the generation of
H2O2 spectrophotometrically, following reaction catalysed
by glucose oxidase using Roche glucose oxidase kit.
Quantification of whole-cell CYP153A6
The functional CYP153A6 protein in whole cells was
quantified using CO-difference spectra [37]. Cell suspen-
sion samples of 1000 μl were placed in 10 ml test tubes
and saturated with carbon monoxide. The samples werereduced immediately by adding sodium dithionite powder.
The absorbance spectra between 400 and 500 nm of
reduced samples with and without CO were recorded
using a UV-Vis spectrophotometer (UNICAM Helios α).
The A450-490 difference was determined and the active con-
centration of the CYP153A6 protein was calculated using
an extinction coefficient of 91 mM-1 cm-1.
Analysis of overflow metabolism through acetic acid
accumulation
The concentration of acetic acid was quantified by high
pressure liquid chromatography (HPLC) using Aminex
HPX-87H column (Bio-Rad). The operating temperature
was 60°C. Separation was achieved using 0.01 M H2SO4
at a flow-rate of 0.6 ml min-1 and analysed by UV ab-
sorbance at 210 nm.
Analysis of octanol formation
The contents of each vial were extracted using 1000 μl of
ethyl acetate containing 0.3% 1-decanol (v/v) as the in-
ternal standard. GC analysis was carried out using a
Varian 3900 series gas chromatograph equipped with a
flame ionisation detector and a non-polar Varian factor
four column (VF–1 ms) composing of dimethylpolysilox-
ane, measuring 15 m × 0.25 mm. The inlet temperature
was 280°C, the flow of nitrogen (carrier gas) through the
column was 15 ml min-1 and the sample volume was 1 μl.
The temperature program used was adapted from
Gudiminchi et al. [19]: isotherm maintained at 120°C
for 5 min, temperature ramped at 20°C min-1 to 280°C,
followed by a 7 min isotherm. Product concentrations
were calculated using a standard curve of 1-octanol in
the range 5 to 100 mM.
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